FutureFuel fell 38.5% after earnings, with the clearest disappointment coming from weak Chemicals segment throughput: customer turnarounds cut sales volume 27% year over year and reduced adjusted EBITDA by about $4.3 million. Biofuel utilization improved, but elevated feedstock costs and derivative losses still drove a segment gross loss.
FutureFuel's shares surged 13.4% after earnings, reflecting investor enthusiasm for the company’s clear strategic roadmap, the inherent value of its integrated manufacturing platform, and prospects for long-term profitable growth.